Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial
2023 · European Urology Oncology · 17 citations
https://doi.org/10.1016/j.euo.2023.07.008